These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8780668)

  • 1. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain.
    Echevarría JM; León P; Domingo CJ; López JA; Elola C; Madurga M; Salmerón F; Yap PL; Daub J; Simmonds P
    Transfusion; 1996 Aug; 36(8):725-30. PubMed ID: 8780668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
    Healey CJ; Sabharwal NK; Daub J; Davidson F; Yap PL; Fleming KA; Chapman RW; Simmonds P; Chapel H
    Gastroenterology; 1996 Apr; 110(4):1120-6. PubMed ID: 8613001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection in hypogammaglobulinemic patients receiving long-term replacement therapy with intravenous immunoglobulin.
    Taliani G; Guerra E; Rosso R; Badolato MC; Luzi G; Sacco G; Lecce R; De Bac C; Aiuti F
    Transfusion; 1995 Feb; 35(2):103-7. PubMed ID: 7825204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status.
    Rossi G; Tucci A; Cariani E; Ravaggi A; Rossini A; Radaeli E
    Blood; 1997 Aug; 90(3):1309-14. PubMed ID: 9242566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
    Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P
    Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection by hepatitis C virus through contaminated intravenous immune globulin: results of a prospective national inquiry in France.
    Lefrère JJ; Loiseau P; Martinot-Peignoux M; Mariotti M; Ravera N; Thauvin M; Marcellin P; Janot C
    Transfusion; 1996 May; 36(5):394-7. PubMed ID: 8693501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study.
    Bresee JS; Mast EE; Coleman PJ; Baron MJ; Schonberger LB; Alter MJ; Jonas MM; Yu MY; Renzi PM; Schneider LC
    JAMA; 1996 Nov; 276(19):1563-7. PubMed ID: 8918853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
    Jonas MM; Baron MJ; Bresee JS; Schneider LC
    Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin.
    Flora K; Schiele M; Benner K; Montanaro A; Johnston W; Whitham R; Press R
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):160-2. PubMed ID: 8595535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin and hepatitis C virus: the Scandinavian experience.
    Björkander J; Fasth A; Widell A
    Clin Ther; 1996; 18 Suppl B():73-82. PubMed ID: 8930444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution].
    Bozdayi G; Rota S; Verdi H; Derici U; Sindel S; Bali M; Başay T
    Mikrobiyol Bul; 2002; 36(3-4):291-300. PubMed ID: 12838663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs.
    Pereira BJ; Milford EL; Kirkman RL; Quan S; Sayre KR; Johnson PJ; Wilber JC; Levey AS
    N Engl J Med; 1992 Sep; 327(13):910-5. PubMed ID: 1325035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. At least three hepatitis C virus strains implicated in Swedish and Danish patients with intravenous immunoglobulin-associated hepatitis C.
    Widell A; Zhang YY; Andersson-Gäre B; Hammarström L
    Transfusion; 1997 Mar; 37(3):313-20. PubMed ID: 9122906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.
    Prescott LE; Simmonds P; Lai CL; Chan NK; Pike I; Yap PL; Lin CK
    J Med Virol; 1996 Oct; 50(2):168-75. PubMed ID: 8915883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus transmission by intravenous immunoglobulin.
    Yap PL; McOmish F; Webster AD; Hammarstrom L; Smith CI; Bjorkander J; Ochs HD; Fischer SH; Quinti I; Simmonds P
    J Hepatol; 1994 Sep; 21(3):455-60. PubMed ID: 7836718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to detect hepatitis C virus (HCV) genome by polymerase chain reaction in human anti-HCV-positive intravenous immunoglobulins.
    Dammacco F; Sansonno D; Beardsley A; Gowans EJ
    Clin Exp Immunol; 1993 May; 92(2):205-10. PubMed ID: 8387411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin.
    Power JP; Lawlor E; Davidson F; Holmes EC; Yap PL; Simmonds P
    Lancet; 1995 May; 345(8959):1211-3. PubMed ID: 7739308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation.
    Lawlor E; Power J; Garson J; Yap P; Davidson F; Columb G; Smith D; Pomeroy L; O'Riordan J; Simmonds P; Tedder R
    Vox Sang; 1999; 76(3):138-43. PubMed ID: 10341327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.